$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000162828019002959 Filed on March 14, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018 Q3
Revenue	$1.853M	$4.014M	$2.829M
YoY Change	4.78%	41.07%	3.12%
Cost Of Revenue	$1.147M	$2.988M	$3.068M
YoY Change	36.31%	99.72%	81.53%
Gross Profit	$706.0K	$1.025M	-$239.6K
YoY Change	-23.84%	-23.98%	-122.76%
Gross Profit Margin	38.1%	25.55%	-8.47%
Selling, General & Admin	$4.791M	$4.600M	$3.224M
YoY Change	65.47%	30.31%	3.44%
% of Gross Profit	678.61%	448.6%
Research & Development	$2.100M	$2.520M	$2.505M
YoY Change	-11.28%	2.44%	-15.57%
% of Gross Profit	297.45%	245.75%
Depreciation & Amortization	$270.0K	$150.0K	$391.2K
YoY Change	-31.03%	-72.22%	62.65%
% of Gross Profit	38.24%	14.63%
Operating Expenses	$6.891M	$7.120M	$5.729M
YoY Change	30.95%	19.06%	-5.83%
Operating Profit	-$6.185M	-$6.095M	-$5.969M
YoY Change	42.66%	31.6%	18.64%
Interest Expense	$273.0K	-$270.0K	$404.4K
YoY Change	-9.6%	68.75%	178.33%
% of Operating Profit
Other Income/Expense, Net	-$1.662M	-$40.00K	$1.040M
YoY Change	-437.89%	-92.31%	-1861.48%
Pretax Income	-$7.847M	-$6.400M	-$4.929M
YoY Change	104.16%	8.11%	-3.17%
Income Tax	$5.000K	$10.00K	-$2.978K
% Of Pretax Income
Net Earnings	-$7.852M	-$6.411M	-$4.926M
YoY Change	104.09%	-208.3%	-196.87%
Net Earnings / Revenue	-423.75%	-159.75%	-174.15%
Basic Earnings Per Share
Diluted Earnings Per Share	-$768.9K	-$633.4K	-$491.5K
COMMON SHARES
Basic Shares Outstanding	10.10M shares	10.03M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q1	2018 Q4	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$20.80M	$16.50M	$20.70M
YoY Change	173.68%
Cash & Equivalents	$20.83M	$16.52M	$20.66M
Short-Term Investments
Other Short-Term Assets	$1.374M	$384.1K	$1.099M
YoY Change	-19.18%	-30.17%
Inventory	$1.406M	$1.069M	$2.615M
Prepaid Expenses
Receivables	$4.057M	$4.514M	$4.001M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$28.01M	$23.03M	$28.62M
YoY Change	103.0%	222.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.537M	$1.777M	$2.049M
YoY Change	-40.88%	-40.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.537M	$1.777M	$2.049M
YoY Change	-43.07%	-40.87%
TOTAL ASSETS
Total Short-Term Assets	$28.01M	$23.03M	$28.62M
Total Long-Term Assets	$1.537M	$1.777M	$2.049M
Total Assets	$29.55M	$24.80M	$30.67M
YoY Change	79.1%	144.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$870.8K	$1.352M	$2.364M
YoY Change	-3.24%	-41.3%
Accrued Expenses	$3.629M	$2.900M	$2.815M
YoY Change	29.6%	-17.35%
Deferred Revenue		$271.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$4.714M	$4.523M	$5.515M
YoY Change	-82.48%	-72.84%
LONG-TERM LIABILITIES
Long-Term Debt	$18.38M	$9.029M	$9.008M
YoY Change
Other Long-Term Liabilities	$287.3K	$808.4K	$767.2K
YoY Change	-52.11%	42.56%
Total Long-Term Liabilities	$18.66M	$9.838M	$9.776M
YoY Change	3010.52%	1634.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.714M	$4.523M	$5.515M
Total Long-Term Liabilities	$18.66M	$9.838M	$9.776M
Total Liabilities	$23.68M	$14.67M	$15.43M
YoY Change	-13.89%	-15.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$80.61M	-$72.76M	-$66.35M
YoY Change		34.08%
Common Stock	$86.48M	$82.90M	$81.59M
YoY Change		1952.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.870M	$10.14M	$15.24M
YoY Change
Total Liabilities & Shareholders Equity	$29.55M	$24.80M	$30.67M
YoY Change	79.1%	144.48%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018 Q3
OPERATING ACTIVITIES
Net Income	-$7.852M	-$6.411M	-$4.926M
YoY Change	104.09%	-208.3%	-196.87%
Depreciation, Depletion And Amortization	$270.0K	$150.0K	$391.2K
YoY Change	-31.03%	-72.22%	62.65%
Cash From Operating Activities	-$6.552M	-$4.090M	-$6.100M
YoY Change	-3.47%	45.55%	7.77%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$10.00K	-$130.0K
YoY Change	-100.0%	-96.43%	-53.57%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$10.00K	-$130.0K
YoY Change	-100.0%	-96.43%	-53.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.410M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$10.86M	-30.00K	19.26M
YoY Change	-18.54%	-102.03%	564.14%
NET CHANGE
Cash From Operating Activities	-$6.552M	-4.090M	-6.100M
Cash From Investing Activities	$0.00	-10.00K	-130.0K
Cash From Financing Activities	$10.86M	-30.00K	19.26M
Net Change In Cash	$4.307M	-4.130M	13.03M
YoY Change	-34.05%	156.52%	-528.62%
FREE CASH FLOW
Cash From Operating Activities	-$6.552M	-$4.090M	-$6.100M
Capital Expenditures	$0.00	-$10.00K	-$130.0K
Free Cash Flow	-$6.552M	-$4.080M	-$5.970M
YoY Change	-3.64%	61.26%	10.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	bngo	Accretion Of Debt Discount AccretionOfDebtDiscount	-96576	USD
CY2018	bngo	Accretion Of Debt Discount AccretionOfDebtDiscount	-181991	USD
CY2017Q4	bngo	Accrued Expenses Current AccruedExpensesCurrent	2596137	USD
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	0	USD
CY2018	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	115464	USD
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2017	bngo	Fair Value Of Warrants Issued With Debt Classified As Liability FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability	0	USD
CY2018	bngo	Fair Value Of Warrants Issued With Debt Classified As Liability FairValueOfWarrantsIssuedWithDebtClassifiedAsLiability	176813	USD
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001411690
CY2017	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	0	USD
CY2018	bngo	Final Payment Fee Due In Connection With Repayment Of Debt Classified Within Other Long Term Liabilities FinalPaymentFeeDueInConnectionWithRepaymentOfDebtClassifiedWithinOtherLongTermLiabilities	400000	USD
CY2018Q4	bngo	Net Worth NetWorth	91000000	USD
CY2017	bngo	Noncash Interest Expense NoncashInterestExpense	0	USD
CY2018	bngo	Noncash Interest Expense NoncashInterestExpense	568483	USD
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10096407	shares
CY2018Q4	bngo	Operating Lease Area Of Sublease OperatingLeaseAreaOfSublease	16607	sqft
CY2018Q4	bngo	Operating Leases Future Minimum Payments Due Net OperatingLeasesFutureMinimumPaymentsDueNet	894093	USD
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018Q4	bngo	Operating Leases Future Minimum Payments Due Next Twelve Months Net OperatingLeasesFutureMinimumPaymentsDueNextTwelveMonthsNet	456015	USD
CY2018Q4	bngo	Operating Leases Future Minimum Payments Duein Two Years Net OperatingLeasesFutureMinimumPaymentsDueinTwoYearsNet	438078	USD
CY2017Q4	bngo	Preferred Stock Warrant Liability Current PreferredStockWarrantLiabilityCurrent	3898944	USD
CY2018Q4	bngo	Preferred Stock Warrant Liability Current PreferredStockWarrantLiabilityCurrent	0	USD
CY2018	bngo	Purchase Obligation Continuous Purchase Period PurchaseObligationContinuousPurchasePeriod	P3M
CY2018	bngo	Purchase Obligation Contract Termination Period PurchaseObligationContractTerminationPeriod	P90D
CY2018	bngo	Purchase Obligation Initial Purchase Period PurchaseObligationInitialPurchasePeriod	P2Y
CY2017	bngo	Tax Cutsand Jobs Act Changein Tax Rate Deferred Tax Asset Income Tax Expense TaxCutsandJobsActChangeinTaxRateDeferredTaxAssetIncomeTaxExpense	-16600000	USD
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2018	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2018Q4	bngo	Accrued Expenses Current AccruedExpensesCurrent	2134981	USD
CY2018	bngo	Adjustments To Additional Paid In Capital Reclassification Of Convertible Preferred Stock Warrant Liability AdjustmentsToAdditionalPaidInCapitalReclassificationOfConvertiblePreferredStockWarrantLiability	84676	USD
CY2018	bngo	Amount Paid As Distributions In Excess Of Net Worth AmountPaidAsDistributionsInExcessOfNetWorth	10000000	USD
CY2017	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	75268	USD
CY2018	bngo	Transfer Of Instruments To Property And Equipment From Inventory TransferOfInstrumentsToPropertyAndEquipmentFromInventory	242831	USD
CY2018Q4	bngo	Annual Future Minimum Royalty Payments AnnualFutureMinimumRoyaltyPayments	90000	USD
CY2017	bngo	Conversion Of Preferred Stock Warrants Into Common Stock And Common Stock Warrants ConversionOfPreferredStockWarrantsIntoCommonStockAndCommonStockWarrants	0	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4514333	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	912757	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2900129	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3921565	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5162364	USD
CY2018	bngo	Conversion Of Preferred Stock Warrants Into Common Stock And Common Stock Warrants ConversionOfPreferredStockWarrantsIntoCommonStockAndCommonStockWarrants	84676	USD
CY2017	bngo	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	255657	USD
CY2018	bngo	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	838137	USD
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	0	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	BioNano Genomics, Inc
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Trading Symbol TradingSymbol	BNGO
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2302964	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1351736	USD
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3614214	USD
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	243160120	shares
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1021897	USD
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	765148	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3508894	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4514333	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3352214	USD
CY2018Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16522729	USD
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77257	shares
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5249620	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1021897	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16522729	USD
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5714588	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4227723	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	15500832	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4038817	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82898775	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	382830	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1193873	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	165000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	382830	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1193873	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	262000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2017	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	225052	USD
CY2018	us-gaap	Amortization Of Lease Incentives AmortizationOfLeaseIncentives	225052	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4141833	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5345354	shares
CY2017Q4	us-gaap	Assets Assets	10145153	USD
CY2018Q4	us-gaap	Assets Assets	24802421	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	7139365	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	23025119	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11830	USD
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3150	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4199733	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10055072	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77257	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10055072	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	8	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	1004	USD
CY2018Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1205264	USD
CY2017Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1638853	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1690223	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1496172	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6030512	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	841449	USD
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1813430	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3068332	USD
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2988115	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8711326	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	6703475	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	7317565	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	6083995	USD
CY2017Q4	us-gaap	Costs And Expenses CostsAndExpenses	6588304	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	26693339	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	5262497	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	5588800	USD
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	5729212	USD
CY2018Q4	us-gaap	Costs And Expenses CostsAndExpenses	7123985	USD
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	23704494	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	16996	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	13955	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	18552	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15511	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1556	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1556	USD
CY2017	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	14898327	USD
CY2016Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0325
CY2016Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	113542	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	211697	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	270998	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	142929	USD
CY2018Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	304467	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35770601	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41407887	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30528420	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35104728	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1163659	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1725577	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4078522	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4577582	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35770601	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35800000	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-7939076	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41407887	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41400000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	395360	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	272507	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1504042	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1320521	USD
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-8.65
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.61
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2888363	USD
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y10M24D
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-751933	USD
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3991081	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-342164	USD
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	604511	USD
CY2018	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-23455215	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-18515638	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23346812	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18480881	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	108403	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	34757	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18552	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15511	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-7523665	USD
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5617471	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	16552989	USD
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3880985	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	426903	USD
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	95852	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-376232	USD
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-476179	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	866710	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	502511	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1541472	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-954377	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1767647	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	900119	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-123229	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-247402	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	336046	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	418984	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-770553	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-152012	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	3311476	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	35776395	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	4926097	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	6411457	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1017830	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-331716	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-18496392	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-128004	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9029374	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17607905	USD
CY2017	us-gaap	Interest Expense InterestExpense	590927	USD
CY2018	us-gaap	Interest Expense InterestExpense	1381024	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	534858	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	700353	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1490657	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	907089	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	1693742	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	1068557	USD
CY2017Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	203085	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	161468	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	364437	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	1287000	USD
CY2017	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2018	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	165000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	17362227	USD
CY2018Q4	us-gaap	Liabilities Liabilities	14665070	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10145153	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24802421	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16652251	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4522863	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6729752	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20817798	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19943847	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	5685530	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	6674458	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	5085452	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	5919924	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-23365364	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	3847362	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1934204	USD
CY2018	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-23218808	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-20415085	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1747224	USD
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	17593610	USD
CY2018	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14295	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3499	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	844812	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	902412	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	853131	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	388797	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	464334	USD
CY2018	us-gaap	Operating Leases Income Statement Sublease Revenue OperatingLeasesIncomeStatementSubleaseRevenue	0	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	590089	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	556321	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	550063	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	384131	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	567047	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	808366	USD
CY2017	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	289010	USD
CY2018	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	675853	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1017830	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	331716	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1071512	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	919500	USD
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	29119	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	460684	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	14329843	USD
CY2017	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2018	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	9500646	USD
CY2017	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2018	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	19389978	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-23365364	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-18496392	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6927353	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6939666	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	567442	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3005788	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1777302	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	262000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-262000	USD
CY2018	us-gaap	Royalty Expense RoyaltyExpense	377437	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14079658	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14220331	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	382830	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1193873	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00
CY2018	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	22179	shares
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	115464	USD
CY2017Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	121992497	shares
CY2017	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2451121	USD
CY2018Q4	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	165000	USD
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7447571	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12009170	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9484163	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	252594	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	252594	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-54266036	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72762428	USD
CY2017Q1	us-gaap	Revenues Revenues	1720754	USD
CY2017Q2	us-gaap	Revenues Revenues	2196110	USD
CY2017Q3	us-gaap	Revenues Revenues	2743056	USD
CY2017Q4	us-gaap	Revenues Revenues	2845123	USD
CY2017	us-gaap	Revenues Revenues	9505043	USD
CY2018Q1	us-gaap	Revenues Revenues	1768485	USD
CY2018Q2	us-gaap	Revenues Revenues	3390009	USD
CY2018Q3	us-gaap	Revenues Revenues	2828704	USD
CY2018Q4	us-gaap	Revenues Revenues	4013537	USD
CY2018	us-gaap	Revenues Revenues	12000735	USD
CY2017	us-gaap	Royalty Expense RoyaltyExpense	233128	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14295	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3499	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-27258972	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-50227211	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	10137351	USD
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5
CY2018Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.0467
CY2017Q4	us-gaap	Supplies Supplies	492330	USD
CY2018Q4	us-gaap	Supplies Supplies	74685	USD
CY2017Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	91033766	USD
CY2017Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	218044977	shares
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3018563	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3389136	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	370573	USD
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2701065	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7077126	shares
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash and cash equivalents and accounts receivable. The Company maintains deposits in federally insured major financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institution in which those deposits are held. </font></div><div style="line-height:120%;padding-top:16px;text-align:justify;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s customers are located throughout the world. The Company generally does not require collateral from its customers, but it performs credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled “Accounts Receivable” below. </font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-002959-index-headers.html	Edgar Link	pending
0001628280-19-002959-index.html	Edgar Link	pending
0001628280-19-002959.txt	Edgar Link	pending
0001628280-19-002959-xbrl.zip	Edgar Link	pending
bngo-20181231.xml	Edgar Link	completed
bngo-20181231.xsd	Edgar Link	pending
bngo-20181231_cal.xml	Edgar Link	unprocessable
bngo-20181231_def.xml	Edgar Link	unprocessable
bngo-20181231_lab.xml	Edgar Link	unprocessable
bngo-20181231_pre.xml	Edgar Link	unprocessable
bngo-ex231x20181231.htm	Edgar Link	pending
bngo-ex311x20181231.htm	Edgar Link	pending
bngo-ex312x20181231.htm	Edgar Link	pending
bngo-ex321x20181231.htm	Edgar Link	pending
bngo10k-20181231.htm	Edgar Link	pending
chipa01.jpg	Edgar Link	pending
dnaa01.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grapha01.jpg	Edgar Link	pending
installeda01.jpg	Edgar Link	pending
instrumenta01.jpg	Edgar Link	pending
kita01.jpg	Edgar Link	pending
productsa01.jpg	Edgar Link	pending
publisheda01.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
saphyra01.jpg	Edgar Link	pending
sensitivitya01.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
solutionsa01.jpg	Edgar Link	pending
variationsa01.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2019 Q1 Form 10-K Financial Statement

#000162828019002959 Filed on March 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2019 Q1 Form 10-K Financial Statement

#000162828019002959 Filed on March 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo